Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexalin Technology (NXL) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to $46774.0.

  • Nexalin Technology's Gains from Investment Securities fell 9836.63% to $46774.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $136526.0, marking a year-over-year decrease of 9523.16%. This contributed to the annual value of $3.1 million for FY2024, which is 3460.99% up from last year.
  • As of Q3 2025, Nexalin Technology's Gains from Investment Securities stood at $46774.0, which was down 9836.63% from $32438.0 recorded in Q2 2025.
  • In the past 5 years, Nexalin Technology's Gains from Investment Securities ranged from a high of $2.9 million in Q3 2024 and a low of $1254.0 during Q1 2022
  • Its 4-year average for Gains from Investment Securities is $534965.7, with a median of $38772.0 in 2023.
  • In the last 5 years, Nexalin Technology's Gains from Investment Securities soared by 449266.77% in 2023 and then tumbled by 9857.85% in 2025.
  • Over the past 4 years, Nexalin Technology's Gains from Investment Securities (Quarter) stood at $1340.0 in 2022, then soared by 3727.39% to $51287.0 in 2023, then dropped by 27.48% to $37195.0 in 2024, then grew by 25.75% to $46774.0 in 2025.
  • Its Gains from Investment Securities was $46774.0 in Q3 2025, compared to $32438.0 in Q2 2025 and $20119.0 in Q1 2025.